Reports of potential bidding war over LloydsPharmacy
LloydsPharmacy could be the target of a three-way bidding war fought among financial investors over the next few weeks, it has been reported.
Sky News reported yesterday (July 19) that formal bids are expected this week from Aurelius Group, Epiris and HIG Europe, all of which it described as having “track records at buying underperforming assets and attempting to revive them,” with Barclays advising Lloyds parent company McKesson.
"People close to the process" told Sky that it will likely take several weeks before the successful bid is identified.
This follows several months of talks between McKesson and prospective bidders, as well as the recent announcement that McKesson’s operations in France, Italy, Ireland, Portugal, Belgium and Slovenia are all being sold to the Germany-based Phoenix Group.
LloydsPharmacy has struggled in recent years, recently reporting that in 2019-20 it made a £175m loss despite attempts to manage costs through closing and selling many of its stores.
However, its online dispensing arm, which recently rebranded from Echo to LloydsDirect, has grown rapidly during the pandemic and announced earlier this month that it had surpassed 500,000 patient nominations.
Meanwhile, McKesson-owned AAH is the UK's largest pharmaceutical wholesaler.
A spokesperson for HIG Europe told Pharmacy Network News that the bid was being managed by HIG Capital’s Miami office, but could not provide any further details.
McKesson, Aurelius and Epiris all told PNN they were unable to comment when approached.
Understand how fungal nail infections develop and help manage customer expectations around treatment
Upgrade your contraceptive consultations by exploring the interactive pack to learn about a daily oral contraceptive pill
Record my learning outcomes
Inspiring stories related to health, fitness and the pursuit of wellbeing
More like this
Covid treatment trial to look at inhaled corticosteroid
The inhaled corticosteroid budesonide has been added to Oxford University’s PRINCIPLE trial looking at potential Covid-19 treatments that prevent hospital admission.
1 Min Article
Pharmacists will be included in £60k life assurance scheme
After coming under pressure this week, Hancock confirms community pharmacists are eligible for the death in service scheme.
1 Min Article
Growth of pharmacy flu jabs ‘far surpasses’ general practice
Community pharmacies have vaccinated over one million more patients against influenza in the 2020-21 flu season than in the previous year.
1 Min Article
Managing heartburn and indigestion in the pharmacy
Learn how to identify and help customers manage heartburn and indigestion, from recommending the right products to ease symptoms, to self-care advice and identifying red flags for referral
22 Min Module
Abdominal discomfort: Multi-symptom relief with Buscomint
Discover the key benefits of a product that offers multi-symptom relief from abdominal pain, cramps and bloating, plus lifestyle advice to help manage symptoms.
10 Min Module